← Database
M&A

EDL

Acquired by

DENTRESSANGLE

FRANCE Software EV [100m EUR - 500m EUR] 09/2024

Target

EDL

Acquirer

DENTRESSANGLE

Context

DENTRESSANGLE Capital acquired a majority stake in EDL from the private equity firm Abenex. This transaction was carried out at a high valuation multiple, reflecting EDL's exceptional profitability (50% EBITDA margin) and dominant market position. The management team reinvested significantly alongside DENTRESSANGLE. The strategic rationale for this "LBO bis" is to accelerate EDL's European footprint through targeted build-up acquisitions and to enhance its technological lead by further integrating AI into the Xplore suite. This transaction marks a successful exit for Abenex, which had supported the group since 2021, overseeing its expansion into the DACH region and Belgium.

EDL, which reported an EBITDA margin of LOGIN in 2023, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN premium to the 13.1x average currently observed in the TMT (Tech, Media, Telecom) sector.

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in TMT (Tech, Media, Telecom) market trends

Target

EDL is a leading European software publisher specialized in medical imaging and diagnostic services. The company's flagship product, the Xplore software suite, provides public and private healthcare institutions with a full-web, integrated solution designed to optimize the operation of medical imaging platforms. EDL s solutions are highly regarded for their technical robustness, ergonomics, and functional depth, covering everything from appointment scheduling to billing and teleradiology.

Ent. Value

LOGIN

Equity Value

LOGIN

Multiples Analysis

EV / Revenue

LOGIN

EV / EBITDA

LOGIN

EV / EBIT

LOGIN

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2023
LOGIN
LOGIN
LOGIN
2022
LOGIN
LOGIN
LOGIN

Other operations with EDL

DateAcquirerTargetCountrySectorDeal Context
05/2021ABENEXEDLFRANCEHealthcare

Abenex acquired a majority stake in EDL from its founders. This primary LBO aimed to professionalize the group's governance, provide it with the financial resources necessary to implement a buy-and-build strategy, and finally to transform the company from its position as a leader in France into a major European platform.

mynth data is contributed by M&A / PE professionals and systematically cross-verified against private deal documents and official releases. All source materials are destroyed post-validation to guarantee data anonymity and compliance.